HIF-1, 2α, the potent factors of tumor angiogenesis, play essential roles in the mechanisms of recurrence of HCC after ablation and are of great significance for the efficacy evaluation of ablation of patients with HCC and the development of individualized treatment options. This evidence concerns the gene HIF1A and hepatocellular carcinoma.